Related Experiment Video
Updated: Jul 5, 2025

08:56
Study of Experimental Organ Donation Models for Lung Transplantation
Published on: March 15, 2024
1.7K
Blood Donor Incentives across 63 Countries: The BEST Collaborative Study
Caroline Graf1, Krystal Oteng-Attakora2, Eamonn Ferguson3
1Department of Sociology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Department of Donor Medicine Research, Sanquin Research, Amsterdam, the Netherlands.
Transfusion Medicine Reviews
|January 16, 2024
Summary
Financial and non-financial incentives for blood donors vary globally. Many countries offer high-value incentives, often contradicting World Health Organization guidelines, to ensure sufficient blood supply.
Area of Science:
- Public Health
- Health Policy
- Behavioral Economics
Background:
- Ensuring a sufficient blood supply is critical for healthcare systems worldwide.
- Incentives for blood donors are a debated strategy to meet this need.
- Global knowledge regarding specific incentive policies is limited.
Purpose of the Study:
- To comprehensively describe incentive policies for whole blood donors across 63 countries and the 50 United States states.
- To analyze the types, values, and geographical distribution of these incentives.
- To compare current practices with World Health Organization (WHO) guidelines.
Main Methods:
- Conducted two surveys among representatives of blood collection establishments.
- Integrated data from an existing study and the World Health Organization (WHO).
- Performed web content analysis of blood collector websites and news releases for extended data.
Main Results:
- Approximately half of surveyed countries utilize financial incentives (cash, tax benefits) and non-financial incentives (healthcare supplements, raffles).
- Time off work is a common incentive, with variations in duration and eligibility.
- Incentive policies show geographical clustering, with neighboring countries often sharing similar approaches.
- Half of the countries surveyed offer high-value incentives, diverging from WHO guidelines.
Conclusions:
- Significant global diversity exists in blood donor incentive policies.
- Current practices, particularly high-value incentives, often contrast with WHO recommendations.
- Development of context-specific, realistic guidelines may be necessary to maintain adequate blood supplies.
Related Concept Videos
Blood Transfusion
562
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
562
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Bone Marrow Sampling and Transplants
332
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
332

